Oxford BioMedica (United Kingdom)

Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Oxford BioMedica (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.

Open Access Percentage

75%

Total
Publications

Total Open
Publications

Total
Citations

192K

Open Access
Percentage

75%

Total
Publications

Total Open
Publications

Total
Citations

192K

Wikipedia

Website

download

Breakdown

Publisher Open

14%

Both

47%

Other Platform Open

14%

Closed

25%

Percentage of Open Access over time

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

Open

Closed

Publisher Open

OA Journal 45%

1.1K

Hybrid 34%

779

No Guarantees 21%

477

Other Platform Open

Domain 71%

1.7K

Institution 50%

1.2K

Preprint 14%

329

Other Internet 11%

264

Public 3%

Other Platform Locations

Name	Platform Type	Publications
PubMed Central	Domain	1.7K
University of Oxford	Institution	335
DOI	Other Internet	248
Royal Netherlands Academy of Arts and Sciences	Institution	219
King's College London	Institution	153
bioRxiv	Preprint	151
University of Cambridge	Institution	148
medRxiv	Preprint	148
Imperial College London	Institution	125
Europe PMC	Domain	118

1 / 19

Data updated 18 August 2025